Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

BeiGene initiates phase I study of BGB-A317 for advanced cancer

June 9, 2015

BMS starts phase I/IIa trial of ADC in solid tumors

June 9, 2015

Scientists disclose phase I results for G-305

June 8, 2015

Janssen initiates rolling BLA submission for daratumumab in multiple myeloma

June 8, 2015

Phase III trial of dendritic cell vaccine for RCC recommended to continue

June 8, 2015

FDA clears IND for phase II trial of ADXS-HPV and epacadostat in cervical cancer

June 5, 2015

Weill Cornell Medical College and Cellectis enter strategic translational research alliance in AML

June 5, 2015

Amgen to collaborate with Roche on phase Ib study of talimogene laherparepvec with atezolizumab

June 4, 2015

Nektar and MD Anderson Cancer Center to collaborate on phase I/II trials of NKTR-214

June 4, 2015

Peregrine and Memorial Sloan Kettering Cancer Center to collaborate on antibody platform

June 3, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...